Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Add filters

Document Type
Year range
Radiol Infect Dis ; 7(4): 186-194, 2020 Dec.
Article in English | MEDLINE | ID: covidwho-697028


OBJECTIVE: To investigate the low-dose chest computed tomography (CT) presentation and dynamic changes in patients with novel coronavirus disease 2019 (COVID-19) to improve understanding of this highly infectious disease. METHODS: The clinical and CT data of 16 patients with COVID-19 were retrospectively analyzed. Dynamic CTs were performed continuously after admission. RESULTS: Of the patients, 14 were moderate cases, and 2 were severe. Twelve patients underwent CT at the early onset stage. Single nodules or ground-glass opacities (GGOs) were found in 2 patients and multiple bilateral pulmonary lesions in 8 (consolidation-like opacities with or without small nodules in five and large GGOs with interlobular septal thickening in three). Ten had lesion growth and enlargement on the second CT. Fourteen patients underwent CT during the progressive stage, which revealed GGOs and focal consolidation in 6 of them, lung consolidation opacities in 5, and simple, large GGOs with interlobular septal thickening in 3. In both severe cases, the lesions continued to enlarge and grow, and the extent of consolidation continued to expand. CONCLUSION: Low-dose chest CT can clearly reflect the morphology, density, and extent of COVID-19 nodules, and is beneficial for observing dynamic nodule changes and disease screening and monitoring.

Radiol Infect Dis ; 7(2): 81-83, 2020 Jun.
Article in English | MEDLINE | ID: covidwho-232724


Coronavirus disease 2019 (COVID-19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is mainly characterized by pulmonary inflammation. The preferred imaging modality is chest computed tomography (CT) which plays an important role in early diagnosis, quarantine, and treatment as well as in the evaluation of therapeutic efficacy. We report the imaging data from a confirmed case of COVID-19 admitted to our hospital. Our aims are to improve understanding of this disease and to facilitate early diagnosis and evaluation of therapeutic efficacy. A 70-year-old woman living in the epidemic area presented with a 2-day history of intermittent fever. Chest CT revealed multiple ground glass opacities in both lungs, mainly distributed subpleurally and in the middle and lateral lung fields, particularly in the right lung, where they had partially fused into patches. Local interlobular septal thickening was also observed. Throat swabs were positive for the SARS-CoV-2 nucleic acid, which confirmed the diagnosis of COVID-19. Chest CT plays a key role in the diagnosis of COVID-19, providing an accurate diagnosis and is a sensitive technique for evaluation of therapeutic efficacy. It has the advantages of promptness, convenience, and high efficiency.